Nitroglycerin In Dextrose Injection
NDC Package 0338-1049-02
Package Information
Nitroglycerin In Dextrose (nitroglycerin) injection is a medication used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease). This formulation utilizes a injection delivery system. Marketed by Baxter Healthcare Company, this product is identified by NDC 0338-1049 and is authorized under FDA application NDA019970.
Identification & Billing
- RxCUI: 1868494 - nitroglycerin 100 MG in 250 ML Injection
- RxCUI: 1868494 - 250 ML nitroglycerin 0.4 MG/ML Injection
- RxCUI: 1868494 - 250 ML NTG 0.4 MG/ML Injection
- RxCUI: 1868494 - 250 ML TNG 0.4 MG/ML Injection
- RxCUI: 1868494 - nitroglycerin 100 MG per 250 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0338 - Baxter Healthcare Company
- 0338-1049 - Nitroglycerin In Dextrose
- 0338-1049-02 - 12 BOTTLE, GLASS in 1 BOX / 250 mL in 1 BOTTLE, GLASS
- 0338-1049 - Nitroglycerin In Dextrose
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0338-1049-02 identifies a specific commercial package of 12 bottle, glass in 1 box / 250 ml in 1 bottle, glass of Nitroglycerin In Dextrose, a human prescription drug labeled by Baxter Healthcare Company. This injection is formulated for intravenous use and contains nitroglycerin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Baxter Healthcare Company on December 29, 1989. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease). It may also be used before physical activities (such as exercise, sexual activity) to help prevent chest pain. Nitroglycerin belongs to a class of drugs known as nitrates. Angina occurs when the heart muscle is not getting enough blood. This drug works by relaxing and widening blood vessels so blood can flow more easily to the heart.
How is this Baxter Healthcare Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00338104902. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
